---
title: "Chun Guang Intelligent (920810): Won the procurement project of Guangzhou Baiyunshan Hutchison Whampoa Chinese Medicine Co., Ltd., with a bid amount of 2.397 million yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/288369433.md"
description: "Chun Guang Intelligent (920810) announced that it won the bid for a procurement project from Guangzhou Baiyunshan Huaji Pharmaceutical Co., Ltd., with an amount of 2.397 million yuan. The company mainly engages in packaging machinery and other equipment, with a revenue of 130 million yuan and a net profit of 1 million yuan in 2025; in the first quarter of 2026, the revenue was 31 million yuan, and the net profit was -2 million yuan"
datetime: "2026-06-02T05:35:15.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/288369433.md)
  - [en](https://longbridge.com/en/news/288369433.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/288369433.md)
---

# Chun Guang Intelligent (920810): Won the procurement project of Guangzhou Baiyunshan Hutchison Whampoa Chinese Medicine Co., Ltd., with a bid amount of 2.397 million yuan

According to Tongbi Finance, data from Qichacha shows that based on the "Announcement of the Bidding Results for the Plastic Bottle Packaging Line Transformation Project of Guangzhou Baiyunshan Hutchison Chinese Medicine Co., Ltd.", Liaoning Chunguang Intelligent Equipment Group Co., Ltd. announced on June 2, 2026, that it won the bid for the procurement project of Guangzhou Baiyunshan Hutchison Chinese Medicine Co., Ltd., with a bid amount of 2.397 million yuan.

Related listed company: Chunguang Intelligent (920810.BJ)

_Tongbi Finance Tip:_

_Chunguang Intelligent (920810.BJ) reported an operating income of 130 million yuan in 2025, with a revenue growth rate of 65.74%. The net profit attributable to the parent company was 1 million yuan, with a net profit growth rate of 102.54%, and a return on equity of 0.54%._

_In the first quarter of 2026, the company's operating income was 31 million yuan, with a revenue growth rate of -31.01%. The net profit attributable to the parent company was -2 million yuan, with a net profit growth rate of -150.95%._

_Currently, the company belongs to the healthcare industry, with main product types including packaging machinery, liquid filling equipment, and intelligent packaging production lines. The 2025 report shows the main composition of its business as pharmaceutical packaging equipment: 79.66%; accessory series: 8.55%; food packaging equipment: 6.65%; other products: 4.59%; other businesses: 0.55%._

### Related Stocks

- [00874.HK](https://longbridge.com/en/quote/00874.HK.md)
- [600332.CN](https://longbridge.com/en/quote/600332.CN.md)

## Related News & Research

- [China Pig Farming Giant Muyuan Expands Board as Founder Retires, Son Joins](https://longbridge.com/en/news/288401079.md)
- [Broadcom surges after unveiling broadband Edge AI portfolio products](https://longbridge.com/en/news/288424412.md)
- [Muyuan Foods to Expand Board, Add Employee Director and Lifetime Honorary Chairman](https://longbridge.com/en/news/288330883.md)
- [US importer files class action against indicted shipping container manufacturers](https://longbridge.com/en/news/288606607.md)
- [Muyuan Foods Sets Out Board Structure and Committee Roles](https://longbridge.com/en/news/288333915.md)